Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$537K Sell
1,525
-9
-0.6% -$3.21K 0.19% 94
2025
Q4
$502K Hold
1,534
0.2% 94
2025
Q3
$433K Sell
1,534
-620
-29% -$180K 0.17% 99
2025
Q2
$601K Buy
2,154
+9
+0.4% +$2.55K 0.25% 79
2025
Q1
$668K Sell
2,145
-13
-0.6% -$3.84K 0.32% 71
2024
Q4
$562K Sell
2,158
-51
-2% -$15.1K 0.26% 79
2024
Q3
$712K Hold
2,209
0.33% 74
2024
Q2
$690K Sell
2,209
-20
-0.9% -$5.88K 0.34% 71
2024
Q1
$634K Sell
2,229
-497
-18% -$145K 0.32% 74
2023
Q4
$785K Sell
2,726
-605
-18% -$165K 0.47% 57
2023
Q3
$895K Buy
3,331
+265
+9% +$66.1K 0.62% 43
2023
Q2
$681K Sell
3,066
-250
-8% -$58K 0.46% 62
2023
Q1
$802K Sell
3,316
-126
-4% -$30.9K 0.52% 56
2022
Q4
$904K Buy
+3,442
New +$923K 0.52% 59

Other funds holding AMGN

Centennial Bank's AMGN Position: Q1 2026 in Review

Centennial Bank reduced its Amgen (AMGN) stake by 0.59% in Q1 2026, selling an estimated $3.21K and leaving 1,525 shares worth $537K. The position accounts for 0.19% of the portfolio, ranked #94.

Centennial Bank first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $904K in Q4 2022. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Centennial Bank held 1,525 shares of Amgen worth $537K as of Q1 2026.
  • Centennial Bank sold 9 Amgen shares in Q1 2026, an estimated $3.21K.
  • Amgen made up 0.19% of Centennial Bank's portfolio in Q1 2026, its #94 holding.
  • Centennial Bank first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Centennial Bank's Amgen position peaked at $904K in Q4 2022.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Centennial Bank's 13F filing for Q1 2026, filed 6 May 2026.